Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | 177Lu-FF58 |
Synonyms | |
Therapy Description |
Limited information is currently available on 177Lu-FF58, a putative radioligand therapy (Dec 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
177Lu-FF58 | 177LuFF58 | Limited information is currently available on 177Lu-FF58, a putative radioligand therapy (Dec 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05977322 | Phase I | 177Lu-FF58 | A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. | Active, not recruiting | USA | NLD | ITA | ISR | ESP | CHE | 0 |